Which echocardiographic and biochemical markers can predict mortality risk for children with hypertrophic cardiomyopathy?
For children with hypertrophic cardiomyopathy (HCM), doctors use echocardiograms (heart ultrasounds) and blood tests to estimate the risk of death. Key markers include the size of the left atrium, the thickness of the heart wall, and levels of certain proteins like NT-proBNP. These markers help guide treatment decisions.
What the research says
A 2024 study of 41 children with HCM found that several echocardiographic measurements were linked to a higher risk of cardiovascular death 3. These included greater left ventricular wall thickness and larger left atrial diameter. The study also identified biochemical markers such as higher levels of NT-proBNP (a protein released when the heart is stressed) as significant predictors 3. Another study in adults with HCM confirmed that left atrial size is a strong predictor of death from heart failure, with a dimension over 48 mm doubling the risk 10. In children, similar thresholds may apply, though specific cutoffs need further validation 3. Additionally, research on adults shows that NT-proBNP and MR-proANP (another heart-related protein) are both strongly linked to death or heart failure hospitalization 9. While most studies focus on adults, the same markers are being investigated in children 36. A review of plasma proteins in MYBPC3 gene carriers also identified NT-proBNP, GDF-15, and FGF-23 as markers of HCM severity, which may predict outcomes 6.
What to ask your doctor
- What is my child's left atrial size and left ventricular wall thickness on the echocardiogram, and how do these numbers compare to normal values?
- Have we measured NT-proBNP or other heart-related proteins in my child's blood, and what do the levels indicate?
- Based on these markers, what is my child's estimated risk of heart-related complications or death?
- How often should we repeat these tests to monitor changes over time?
- Are there any treatments or lifestyle changes that could lower these risk markers?
This question is drawn from common patient questions about this topic and answered using cited medical research. We do not provide individualized advice.